Top Stories
-
-
3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023
3Spine MOTUS Lumbar Total Joint…
Read More » -
-
-
OrthAlign Inc Celebrates a Record Year with Over $50MM in Global Revenue in 2023
The future is brighter, now…
Read More » -
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
Massimo Calafiore begins as President…
Read More » -
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan
Partnership aims to include Aclarion’s…
Read More » -
-
Zimmer Biomet Announces Appointment of Louis A. Shapiro to Board of Directors
WARSAW, Ind., Jan. 5, 2024 /PRNewswire/ —…
Read More » -
Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2
RENOVITE® BMP-2 is being developed as…
Read More » -
Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion
If approved, the breakthrough product…
Read More » -
CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market
The first Korean developed medical…
Read More » -
-
-
Case Study: Reverse Hip Replacement System May Provide Greater Stability – Especially with Spinal Pelvic Disorders
Reverse HRS Case Study, Stephen…
Read More »